Spinal Muscular Atrophy - The disease and its treatments

Main Article Content

Kyra Y. Chen*

Downloads

Download data is not yet available.

Article Details

Chen, K. Y. (2021). Spinal Muscular Atrophy - The disease and its treatments. Archives of Community Medicine and Public Health, 7(2), 138–141. https://doi.org/10.17352/2455-5479.000153
Mini Reviews

Copyright (c) 2021 Chen KY.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Spinal Muscular Atrophy: MedlinePlus Genetics. MedlinePlus, U.S. National Library of Medicine. Link: https://bit.ly/3hHkHjd

Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, et al. (1999) Single Nucleotide Difference That Alters Splicing Patterns Distinguishes the SMA Gene SMN1 From the Copy Gene SMN2. Hum Mol Genet 8: 1177-1183. Link: https://bit.ly/3xMrBJB

About Spinal Muscular Atrophy (SMA). Cure SMA. Link: https://bit.ly/3escdux

Waldrop MA, Elsheikh BH (2020) Spinal Muscular Atrophy in the Treatment Era. Neurol Clin 38: 505–518. Link: https://bit.ly/36GGkKg

Diseases - SMA - Types Of Overview. Muscular Dystrophy Association. Link: https://bit.ly/3xXcRHS

Spinal Muscular Atrophy Fact Sheet. National Institute of Neurological Disorders and Stroke, U.S. Department of Health and Human Services. Link: https://bit.ly/3inqw4O

Treatment for Spinal Muscular Atrophy (SMA). Cure SMA. Link: https://bit.ly/36Jx2xf

Antisense Technology. Ionis Pharmaceuticals, Inc. Link: https://bit.ly/3wM0oFA

Our Medicines. Ionis Pharmaceuticals, Inc. Link: https://bit.ly/3rgluLl

Product Portfolio.

The Discovery of Spinraza. Cure SMA 2018.

Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR (2008) Antisense Masking of an HnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice. Am J Hum Genet 82: 834-848. Link: https://bit.ly/36FJQEJ

Spinraza. Cure SMA. Link: https://bit.ly/3kmvIs8

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy. Biogen. Link: https://bit.ly/2USwTVD

Early-Onset SMA (Type 1): SPINRAZA® (Nusinersen). Official Patient Site. Link: https://bit.ly/3kqLpia

Commissioner (2016) Office of the. FDA Approves First Drug for Spinal Muscular Atrophy. U.S. Food and Drug Administration, FDA. Link: https://bit.ly/3wImLMf

Anonymous. Spinraza. European Medicines Agency. Link: https://bit.ly/36CRxvz

Zolgensma. Cure SMA. Link: https://bit.ly/3wJTvoq

Evrysdi. Cure SMA. Link: https://bit.ly/3z4NaFM

Marta F (2020) Spinraza-Zolgensma Combination Well-Tolerated in Children with SMA. Link: https://bit.ly/2TdAwEW